Status:
COMPLETED
Immunologic Abnormalities, Chronic Inflammation and Oxidative Stress in Chronic Kidney Disease
Lead Sponsor:
University of California, Irvine
Collaborating Sponsors:
Beckman Laser Institute University of California Irvine
Conditions:
Chronic Kidney Disease
Eligibility:
All Genders
18+ years
Brief Summary
The common causes of mortality are late stages of chronic kidney disease, cardiovascular disease and infections, are associated with abnormalities of the immune system, an underlying state of chronic ...
Detailed Description
The Diffuse Optical Spectroscopy can measure the absolute concentrations of reduced and oxygenated hemoglobins,cardiac output, mean arterial pressure, blood loss,blood hemoglobin concentration, water ...
Eligibility Criteria
Inclusion
- 18 years and older with chronic kidney disease undergoing hemodialysis have been treated with hemodialysis for at least 3 months
- 18 years and older for control
Exclusion
- acute kidney disease
Key Trial Info
Start Date :
August 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT00793806
Start Date
August 1 2008
End Date
March 1 2012
Last Update
October 20 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Beckman Laser Institute
Irvine, California, United States, 92612
2
University of California Medical Center: Dialysis Unit
Orange, California, United States, 92868
3
UCIMC Dialysis center
Orange, California, United States, 92869